Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Anti-idiotypic Antibodies against BP-IgG Prevent Type XVII Collagen Depletion
Authors
Keywords
-
Journal
Frontiers in Immunology
Volume 8, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2017-11-27
DOI
10.3389/fimmu.2017.01669
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A randomized double-blind trial of intravenous immunoglobulin for bullous pemphigoid
- (2017) Masayuki Amagai et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Mechanisms of Autoantibody-Induced Pathology
- (2017) Ralf J. Ludwig et al. Frontiers in Immunology
- Eosinophils in Autoimmune Diseases
- (2017) Nicola L. Diny et al. Frontiers in Immunology
- Effects of Intravenous Immunoglobulins on Mice with Experimental Epidermolysis Bullosa Acquisita
- (2015) Misa Hirose et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Immunomodulation by IVIg and the Role of Fc-Gamma Receptors: Classic Mechanisms of Action after all?
- (2015) Sietse Q. Nagelkerke et al. Frontiers in Immunology
- Bullous pemphigoid: role of complement and mechanisms for blister formation within the lamina lucida
- (2013) Hiroaki Iwata et al. EXPERIMENTAL DERMATOLOGY
- Antibodies to Pathogenic Epitopes on Type XVII Collagen Cause Skin Fragility in a Complement-Dependent and -Independent Manner
- (2012) K. Natsuga et al. JOURNAL OF IMMUNOLOGY
- Genetic identification and functional validation of FcγRIV as key molecule in autoantibody-induced tissue injury
- (2012) Michael Kasperkiewicz et al. JOURNAL OF PATHOLOGY
- Pemphigoid diseases
- (2012) Enno Schmidt et al. LANCET
- Intravenous immunoglobulin in the treatment of autoimmune bullous dermatoses: An update
- (2011) Annette Czernik et al. AUTOIMMUNITY
- Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up
- (2011) A.R. Ahmed et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Anti-idiotypes against anti-neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis
- (2010) F. ROSSI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Efficacy of intravenous immunoglobulin (IVIG) affinity-purified anti-desmoglein anti-idiotypic antibodies in the treatment of an experimental model of pemphigus vulgaris
- (2010) D. Mimouni et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- An ‘n-of-1’ placebo-controlled crossover trial of intravenous immunoglobulin as adjuvant therapy in refractory pemphigus vulgaris
- (2009) D.F. Arnold et al. BRITISH JOURNAL OF DERMATOLOGY
- High-Dose Intravenous Immunoglobulin (IVIG) Therapy in Autoimmune Skin Blistering Diseases
- (2009) Norito Ishii et al. CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY
- IgG from Patients with Bullous Pemphigoid Depletes Cultured Keratinocytes of the 180-kDa Bullous Pemphigoid Antigen (Type XVII Collagen) and Weakens Cell Attachment
- (2009) Hiroaki Iwata et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A randomized double-blind trial of intravenous immunoglobulin for pemphigus
- (2009) Masayuki Amagai et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model
- (2008) Zhi Liu et al. JOURNAL OF AUTOIMMUNITY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started